Rosetta Genomics LtdRosetta Genomics Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Alternative companies in the scoring peer group for Rosetta Genomics Ltd are displayed below. This page includes a questions and answers section about Rosetta Genomics Ltd. The report of Rosetta Genomics Ltd uses data points from across the internet as well as from public documents by Rosetta Genomics Ltd.

Rosetta Genomics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.

SDG Transparency Score for Rosetta Genomics Ltd 

0.0

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Rosetta Genomics Ltd 
0.0

Environmental

0.0

Social

0.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
2747Aphria Inc
0.3
Low
2747Sichuan Languang Development Co Ltd
0.3
Low
2749Rosetta Genomics Ltd
0.0
Low
2749Alpha Group Industries Inc
0.0
Low
2749BNC Korea Co Ltd (Pre-Merger)
0.0
Low
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Rosetta Genomics Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd offer flexible work?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Rosetta Genomics Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose water use targets?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Rosetta Genomics Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Rosetta Genomics Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Rosetta Genomics Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Rosetta Genomics Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Rosetta Genomics Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Rosetta Genomics Ltd
These potential risks are based on the size, segment and geographies of the company.

Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.

Sorry!

Failed to process!